Connect Biopharma
Connect Biopharma is a treatments for autoimmune diseases and inflammation founded in 2012 by Zheng Wei.
3
Funding Rounds
$190.0m
Money raised
Overview
Connect Biopharma is a treatments for autoimmune diseases and inflammation founded in 2012 by Zheng Wei.
- Website:
- Business model: B2B
- Headquarters: Jiangsu
- Social accounts: linkedin
Funding
Funding series
Funding Series Analysis
The company Connect Biopharma has raised a total of $135m in funding over 3 rounds.
Key Insights:
- Connect Biopharma Series C round, August 2020: $115m
- Connect Biopharmaceuticals Series A round, January 2017: $20m
- Connect Biopharma funding round, January 2019: $55m
Connect Biopharma Series C round, August 2020
$115m
Connect Biopharmaceuticals Series A round, January 2017
$20m
Connect Biopharma funding round, January 2019
$55m
Industries
Connect Biopharma is active in the following industries: